BREAKING: SCOTUS says IPRs should be reviewable in Arthrex; hands more power to USPTO director
The US Supreme Court has confirmed that judges for the Patent Trial and Appeal Board (PTAB) act as unconstitutional principal officers, and should therefore have been appointed by the President, in its final ruling in United States v Arthrex.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
22 June 2021 In a decision highly anticipated by patent owners, the US Supreme Court has delivered its final ruling in US v Arthrex—a fractured opinion that lawyers say leaves burning questions around its political implications.
17 August 2022 Cybersecurity company wanted to force the USPTO to consider rehearings of inter partes reviews | Window for such director reviews is not ‘nailed shut’ says judge | Case differed from Arthrex.